Clinical significance of gastric food residue in gastrointestinal hereditary transthyretin amyloidosis

Amyloid · Published 2026-08-04 · DOI 10.1080/13506129.2026.2711435

Authors (6)

Takuma Okamura, Yugo Iwaya, Nagaaki Katoh, Yoshiki Sekijima, Hiroyoshi Ota, Tadanobu Nagaya

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Okamura, T., Iwaya, Y., Katoh, N., et al. (2026). Clinical significance of gastric food residue in gastrointestinal hereditary transthyretin amyloidosis. Amyloid. https://doi.org/10.1080/13506129.2026.2711435

Related articles

• Determinants of gastrointestinal disease burden and survival in systemic AL amyloidosis · Blood Advances · 2025 · Cites or is cited by this article
• ALyzer3D.AI: a more generalizable deep learning predictor of light chain amyloidogenicity powered by structural and evolutionary Artificial Intelligence · Amyloid · 2025 · Same journal
• Long-term efficacy and safety of vutrisiran in hereditary transthyretin amyloidosis with polyneuropathy: final analysis of the HELIOS-A randomized treatment extension · Amyloid · 2026 · Same journal
• Limited diagnostic utility of systematic Congo red staining in bone marrow biopsies · Amyloid · 2025 · Same journal
• Clinical profile and outcome of AA amyloidosis associated kidney disease in India · Amyloid · 2025 · Same journal
• Medin and transthyretin: a new amyloid double act in the aortic wall and valves · Amyloid · 2025 · Same journal
• Clinical and radiological stabilization following vutrisiran treatment in transthyretin leptomeningeal amyloidosis: a case report · Amyloid · 2025 · Same journal
• Proline-rich, polybasic peptides are a structurally distinct class of amyloid-reactive peptides · Amyloid · 2026 · Same journal
• Cardiac Phenotype and Clinical Outcomes in Randall Disease versus Light-Chain Amyloidosis · Amyloid · 2025 · Same journal
• Detection yield of surrogate tissue biopsies across amyloidosis classes: a large-scale analysis of 4,027 patients · Amyloid · 2025 · Same journal